Phase 2 significant effects. by Wendy C. Crone (2262169)

Phase 1 significant effects. by Wendy C. Crone (2262169)

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…Compared to PBS-treated, the number of regenerating axons is doubled by ATRA treatment, decreased by 30% by clodronate, and, in the case of ATRA combined with clodronate, is not significantly different.…”

The relative duration and distance in each time gap. by Tomohiro Gonjo (8825780)

Results of mean differences. by Ekkarat Meephu (15307058)

Subjects:

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

Result of mean difference between each of the criteria. by Ekkarat Meephu (15307058)

Subjects:

Effects of s-ketamine and midazolam on respiratory parameters. by Oscar F. C. van den Bosch (22184246)

Subjects:

Mean±SD of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Means, standard deviations and intercorrelations. by Cheri Ostroff (13868468)

Subjects:

Networks of affect states: Significant paths. by Anna Kuranova (8460411)

“…Dashed red edges represent negative connections, meaning that the decrease in one node variable at time point t-1 is associated with decrease in the other variable at time t. …”

Significant results of the MR analysis. by Nikolina Pleić (18858220)

Statistically-significant cytokine changes between the pre-infusion and post-infusion blood draws plot of the mean (dot) and confidence interval (whiskers) for the coefficients of... by Jordan K. Abbott (8934239)

Chromatograms presented the specificity of the proposed method. by Ewa Paszkowska (21246702)

Subjects:

Mean, SD, and Pearson correlations between SWB scales scores. by August Håkan Nilsson (12937056)

Subjects:

Mean TTC under different weights. by Jianrong Cai (14245136)

Subjects:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…</p>Objectives<p>To evaluate the safety and efficacy of endolysin gel in treating AD.</p>Methods<p>An infection-driven dermatitis model with AD-like features was established. …”

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…</p>Objectives<p>To evaluate the safety and efficacy of endolysin gel in treating AD.</p>Methods<p>An infection-driven dermatitis model with AD-like features was established. …”